Anthony James Friedman

• Perforce Software, Inc., a provider of solutions to enterprise teams backed by Francisco Partners and Clearlake Capital Group, L.P., in its acquisition of Puppet, an automation software platform which enables users to deliver, update, monitor, and secure software across physical and virtual machines
• Attralus, Inc., a clinical stage biopharmaceutical company focused on developing therapies to improve the lives of patients with systemic amyloidosis, in its US$116 million Series B Preferred Stock financing
• Porch Group, Inc. in its US$100 million acquisition of Homeowners of America, a Managing General Agent and insurance carrier hybrid licensed to operate in 31 states
• Haystack Sciences in its acquisition by insitro, a machine learning-driven drug discovery and development company
• Porch.com, Inc. in its business combination with PropTech Acquisition Corporation, a SPAC, to become a publicly listed company in a transaction valued at US$523 million
• Perforce Software, Inc. in its acquisition of Methodics Holdings, Inc., a leading provider of intellectual property lifecycle management and traceability solutions
• Transworld Systems, Inc., a Clearlake Capital-backed leading analytics-driven provider of accounts receivable management, healthcare revenue cycle and loan servicing solutions, in its acquisition of Alltran Financial Services
• Transworld Systems, Inc., a Clearlake Capital-backed leading analytics-driven provider of accounts receivable management, healthcare revenue cycle and loan servicing solutions, in its acquisition of Altisource Financial Services
• Perforce Software, Inc. in connection with the investment in the company by Francisco Partners
• Clearlake Capital on multiple acquisitions and divestitures
• Clearlake Capital in a number of co-invest transactions, including in Appriss and Eagleview Technologies
• Clearlake Capital in the combination and US$1.26 billion sale of Syncsort and Vision Solutions to Centerbridge Partners
• HBM Healthcare Investments and its affiliates on multiple portfolio company investments in the life sciences sector
• venBio Partners and its affiliates on multiple portfolio company investments in the life sciences sector

*Some of the above matters were handled prior to joining Sidley.